Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia

Revista Brasileira de Hematologia e Hemoterapia

Volumn 37, Issue 6, 2015, Pages 400-405

  Friedrisch, João Ricardo ^a   Cançado, Rodolfo Delfini ^b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

Author keywords

Anemia; Iron deficiency; Therapeutics

Indexed keywords

ALANINE AMINOTRANSFERASE; DEXTRAN; FERRIC CARBOXYMALTOSE; FERRITIN; FERROUS SULFATE; FERUMOXYTOL; HEMOGLOBIN; IRON; TRANSFERRIN;

ANAPHYLAXIS; CHRONIC KIDNEY DISEASE; CONSTIPATION; DIARRHEA; DIZZINESS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DYSGEUSIA; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART FAILURE; HEMATOLOGIC DISEASE; HUMAN; HYPERTENSION; HYPOTENSION; INFLAMMATORY BOWEL DISEASE; INJECTION SITE REACTION; INTESTINE ABSORPTION; IRON DEFICIENCY ANEMIA; IRON STORAGE; IRON THERAPY; MULTICENTER STUDY (TOPIC); NAUSEA; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHOSPHATE BLOOD LEVEL; POSTPARTUM ANEMIA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT SURVEY; UTERUS BLEEDING; VOMITING;

EID: 84952873489     PISSN: 15168484     EISSN: 18060870     Source Type: Journal    
DOI: 10.1016/j.bjhh.2015.08.012     Document Type: Short Survey

References (43)

1. de Benoist B., McLean E., Egli I., Cogswell M. Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia 2008, World Health Organization, Geneva, 41 p.
2. Gaskell H., Derry S., Andrew Moore R., McQuay H.J. Prevalence of anaemia in older persons: systematic review. BMC Geriatr 2008, 8:1.
3. Clinical guideline 39: anaemia management in people with chronic kidney disease (CKD) [Internet] 2006, National Institute for Health and Clinical Excellence, National Institute for Health and Clinical Excellence, UK, Available from: http://guidance.nice.org.uk/CG39 [cited 15.07.14].
4. Silla L.M., Zelmanowicz A., Mito I., Michalowski M., Hellwing T., Shilling M.A., et al. High prevalence of anemia in children and adult women in an urban population in southern Brazil. PLOS ONE 2013, 8(7):e68805.
5. Brugnara C., Beris P. Iron therapy. Disorders of erythropoiesis, erythrocytes and iron metabolism 2009, 512-528. European School of Haematology, Paris. C. Beaumont, P. Beris, Y. Beuzard, C. Brugnara (Eds.).
6. Gisbert J.P., Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 2008, 103(5):1299-1307.
7. Cook J.D. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 2005, 18(2):319-332.
8. Coyne D.W., Auerbach M. Anemia management in chronic kidney disease: intravenous iron steps forward. Am J Hematol 2010, 85(5):311-312.
9. Muñoz M., Gómez-Ramírez S., García-Erce J.A. Intravenous iron in inflammatory Bowell disease. World J Gastroenterol 2009, 15(37):4666-4674.
10. Erichsen K., Ulvik R.J., Nysaeter G., Johansen J., Ostborg J., Berstad A., et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol 2005, 40(9):1058-1065.
11. Gasche C., Waldhoer T., Feichtenschlager T., Male C., Mayer A., Mittermaier C., et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Am J Gastroenterol 2001, 96(8):2382-2387.
12. Gisbert J.P., Bermejo F., Pajares R., Perez-Calle J.L., Rodriguez M., Algaba A., et al. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement. Inflamm Bowel Dis 2009, 15(10):1485-1491.
13. Schroder O., Mickisch O., Seidler U., de Weerth A., Dignass A.U., Herfarth H., et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease - a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 2005, 100(11):2503-2509.
14. Lindgren S., Wikman O., Befrits R., Blom H., Eriksson A., Granno C. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009, 44(7):839-845.
15. Traina F. Deficiência de ferro no paciente submetido à ressecção gástrica ou intestinal: prevalência, causas, repercussões clínicas, abordagem diagnóstica e prevenção. Rev Bras Hematol Hemoter 2010, 32:78-83.
16. Cançado R.D., Lobo C., Friedrich J.R. Tratamento da anemia ferropriva com ferro por via parenteral. Rev Bras Hematol Hemoter 2010, 32:121-128.
17. Cançado R.D., Brasil S.A., Noronha T.G., Chiattone C.S. Avaliação da eficácia do uso intravenoso de sacarato de hidróxido de ferro III no tratamento de pacientes adultos com anemia ferropriva. Rev Bras Hematol Hemoter 2007, 29(2):123-129.
18. Cançado R.D., Brasil S.A., Noronha T.G., Chiattone C.S. O uso intravenoso de sacarato de hidróxido de ferro III em pacientes com anemia ferropriva. Rev Assoc Med Bras 2005, 51(6):323-328.
19. Fernandes N., Abrita R.R., do Carmo W.B., Carvalho G.H., Silva J.H., Lopes T.M., et al. Impacto do tratamento intravenoso com sacarato de hidróxido de ferro III nos marcadores séricos de deficiência de ferro e na hemoglobina sérica em pacientes com doença renal crônica pré-dialítica. J Bras Nefrol 2007, 29(1):33-37.
20. Cançado R.D., Muñoz M. Intravenous iron therapy: how far have we come?. Rev Bras Hematol Hemoter 2011, 33(6):461-469.
21. Abensur H. Deficiência de ferro na doença renal crônica. Rev Bras Hematol Hemoter 2010, 32(Suppl. 2):84-88.
22. Blasco P.G., Levites M.R., Mônaco C. Ferro endovenoso melhora sintomas de pacientes com insuficiência cardíaca que têm deficiência. Diagn Trat 2010, 15(3):125-126.
23. Fabron Júnior A. Ferro endovenoso no tratamento da anemia ferropriva: seguro e eficaz. Rev Bras Hematol Hemoter 2007, 29(2):106-108.
24. Lyseng-Williamsom K.A., Keating G.M. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs 2009, 69(6):739-756.
25. Kulnigg S., Stoinov S., Simanenkov V., Dudar L.V., Karnafel W., Garcia L.C., et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008, 103(5):1182-1192.
26. Anker S.D., Comin Colet J., Filippatos G., Willenheimer R., Dickstein K., Drexler H., et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009, 361(25):2436-2448.
27. Van Wyck D.B., Mangione A., Morrison J., Hadley P.E., Jehle J.A., Goodnough L.T. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion 2009, 49(12):2719-2728.
28. Covic A., Mircescu G. The safety and efficacy of intravenous iron carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study. Nephrol Dial Transplant 2010, 25(8):2722-2730.
29. Macdougall L., Chappeli J., Chai M.O. Iron supplementation: focus on ferric carboxymaltose [Internet] 2010, Hospital Pharmacy Europe, Available from: http://www.hospitalpharmacyeurope.com/featured-articles/iron-supplementation-focus-ferric-carboxymaltose [cited 15.07.14].
30. Jahn M.R., Andreasen H.B., Futterer S., Nawroth T., Schunemann V., Kolb U., et al. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications. Eur J Pharm Biopharm 2011, 78(3):480-491.
31. Singh A., Patel T., Hertel J., Bernardo M., Kausz A., Brenner L. Safety of ferumoxytol in patients with anemia and CKD. Am J Kidney Dis 2008, 52(5):907-915.
32. Provenzano R., Schiller B., Rao M., Coyne D., Brenner L., Pereira B.J. Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients. Clin J Am Soc Nephrol 2009, 4(2):386-393.
33. Lu M., Cohen M.H., Rieves D., Pazdur R. FDA review of ferumoxytol (Feraheme) for the treatment of iron deficiency anemia in adults with chronic kidney disease. Am J Hematol 2010, 859(5):315-319.
34. Braile G. Efficacy and safety of ferricarboximaltose in correcting iron deficiency anemia: a review of randomized controlled trials across different indications. Arzneimittelforschung 2010, 60(6a):386-398.
35. Schaefer R.M., Khasabov N.N., Todorov N.G., Evenepoel P. Intravenous ferric carboxymaltose or iron sucrose to treat iron deficiency anaemia in haemodialysis patients. Poster presented at the XLV ERA-EDTA Congress 2008, (Poster MP375).
36. Van Wyck D.B., Martens M.G., Seid M.H., Baker J.B., Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol 2007, 110(2 (Pt 1)):267-278.
37. Bisbe E., Garcia-Erce J.A., Diez-Lobo A.I., Munoz M. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. Br J Anaesth 2011, 107(3):477-478.
38. Bregman D.B., Goodnough L.T. Experience with intravenous ferric carboximaltose in patients with iron deficiency anemia. Ther Adv Hematol 2014, 5(2):48-60.
39. US Food and Drug Administration Center for Drug Evaluation and Research [Internet]. Available from: [cited 15.07.14]. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/203565Orig1s000MedR.pdf.
40. European Medicines Agency New recommendations to manage risk of allergic reactions with intravenous iron-containing medicines [Internet]. Available from: [cited 15.07.14]. http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/06/WC500144874.pdf.
41. Wolf M., Koch T.A., Bregman D.B. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res 2013, 28(8):1793-1803.
42. Schouten B.J., Hunt P.J., Livesey J.H., Frampton C.M., Soule S.G. FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study. J Clin Endocrinol Metab 2009, 94(7):2332-2337.
43. Froessler B., Collingwood J., Hodyl N.A., Dekker G. Intravenous ferric carboxymaltose for anaemia in pregnancy. BMC Pregnancy Childbirth 2014, 14:115.